Indeed, hotspot mutations in tumor protein p53 (TP53) and isocitrate dehydrogenase 1 (IDH1) were reported to generate antigenic peptides in ovarian cancer and glioma, respectively (26, 27). Here, TP53 is linked to ovarian carcinoma.